|
8:00 – 8:30 |
Breakfast and Registration |
|
|
8:30–8:35 |
Welcome & LLS impact: Advancing Cures |
Lauren Berger, MPH, The Leukemia & Lymphoma Society |
|
8:35–8:45 |
Overview |
David L. Porter, MD, University of Pennsylvania Health System |
|
8:45–9:15 |
CAR T-cell Clinical Applications: Is it Right for My Patients? |
Bhagirathbhai Dholaria, MBBS, Vanderbilt University School of Medicine |
|
9:15–9:45 |
CAR T-cells for Acute Lymphoblastic Leukemia |
Carrie L. Kitko, MD, Vanderbilt University School of Medicine |
|
9:45–10:15 |
CAR T-cells for Non-Hodgkin Lymphoma |
Amitkumar Mehta, MD, University of Alabama Birmingham School of Medicine |
|
10:15–10:30 |
Break |
|
|
10:30–11:00 |
CAR T-cells for Myeloma: The Next Major Disease Target? |
Jesus G. Berdeja, MD, Sarah Cannon Research Institute at Tennessee Oncology |
|
11:00–11:30 |
CAR T-cells for Chronic Lymphocytic Leukemia |
David L. Porter, MD, University of Pennsylvania Health System |
|
11:30–12:00 |
CAR T Toxicity and Management |
M. Paulina Velasquez, MD, St. Jude Children’s Research Hospital |
|
12:00-12:15 |
Q & A |
David L. Porter, MD, Perelman University of Pennsylvania Health System |
| 12:15-12:30 | Lunch Break | |
|
12:30–1:15 |
Meet the Experts: Roundtable discussions facilitated by fellows and symposium faculty |
Dilan A. Patel, MD, Vanderbilt University Medical Center Rebecca Epperly, MD, St. Jude Children’s Research Hospital Ayman Qasrawi, MD, University of Kentucky HealthCare
|
|
1:15 – 2:15 |
Case Presentations: Non-Hodgkin Lymphoma and Myeloma: Referral, Treatment and Follow-up
|
Gerhard C. Hildebrandt, MD, University of Kentucky HealthCare Luciano J. Costa, MD, PhD, University of Alabama Birmingham School of Medicine |
|
2:15–2:45
|
Getting Started: A CAR T Team's Experience |
Edmund K. Waller, MD, PhD, FACP, Emory University School of Medicine |
|
2:45–3:15 |
Commercial CAR-T Coverage and Reimbursement: What a Clinician Needs to Know |
C. Fred LeMaistre, MD, Sarah Cannon Blood Cancer Network |
|
3:15–4:00 |
It Takes a Village: Panel Presentations & Discussion |
Lesley Camille Ballance, MSN, FNP-BC, Sarah Cannon Institute at Tennessee Oncology Brittney Baer, RN, BSN, Vanderbilt University School of Medicine Trista Carelock, RN, BSN, BMTCN® OCN®, Sarah Cannon Blood Cancer Network Mykala Heuer, BSN, RN, Vanderbilt-Ingram Cancer Center |
|
4:00- 4:30 |
Interactive Panel Discussion and Q & A |
David L. Porter, MD & Panel |
